Faculty Opinions recommendation of LBA50 Three-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase III trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要